Congenital heart disease: The State-of-the-Art on its pharmacological therapeutics
CD Varela-Chinchilla, DE Sánchez-Mejía… - Journal of …, 2022 - mdpi.com
Congenital heart disease is one of the most common causes of death derived from
malformations. Historically, its treatment has depended on timely diagnosis and early …
malformations. Historically, its treatment has depended on timely diagnosis and early …
Therapeutic efficacy of catalpol against apoptosis in cardiomyocytes derived from human induced pluripotent stem cells
L Yang, X Feng, Y Li, S Zhang, Y Ying - AMB Express, 2020 - Springer
Cardiac arrhythmia is an irregular heart rhythm that can lead to serious heart conditions and
various organ disorders, and may cause sudden cardiac death. Catalpol belongs to the …
various organ disorders, and may cause sudden cardiac death. Catalpol belongs to the …
Triggered Ventricular Tachyarrhythmias Initiated by Enhanced Late Inward Na and Ca Currents: Novel Therapeutic Targets
HS Karagueuzian - Cardiac Map**, 2019 - books.google.com
Enhanced late ICa‐L and late INa (INa‐L) emerge in congenital and acquired cardiac
diseases such as heart failure and cardiomyopathies. These pathological currents are …
diseases such as heart failure and cardiomyopathies. These pathological currents are …
[CITATION][C] Recent Advances in Cardiac Pharmacology
RC Kashav, PM Kapoor, J Jose… - Textbook of Cardiac …, 2024 - Georg Thieme Verlag